Japan

Overview

Local press, analysts and the companies themselves have increasingly commented on the possible integration of Japanese drugmakers Mitsubishi Pharma and Tanabe Seiyaku. Tanabe would... 2007-01-19

Swiss drugmaker Novartis has launched its consumer healthcare division in Japan and it is planning to become a top 10 player within the next five years. Given the company's diversified... 2007-01-16

Japanese drugmaker Takeda has announced that it will set aside a war chest of JPY1trn (US$8.4bn) for strategic acquisitions, as the company looks to move away from its focus on... 2007-01-08

Japan's leading drugmaker Astellas has announced that it is to divest three of its European production units to German drugmaker Temmler Group. Astellas has previously announced... 2006-12-22

Sales for Japan's leading drugmakers, rose by 6% to JPY2,845.8bn (US$24.5bn) in H106, in what BMI believes is an encouraging performance considering the 6.7% cut in reimbursement... 2006-12-01

Japan could become one of the most important generics markets in Asia as the government looks to encourage this low cost sector as a means of restricting drug expenditure. Foreign... 2006-11-30

Innovative Japanese drugmaker Eisai has received a positive opinion on its anti-epileptic Inovelon (rufinamide) from the European Committee for Medicinal Products (CHMP). The drug... 2006-11-23

UK drug major GlaxoSmithKline (GSK) has filed its salmeterol + fluticasone propionate combination drug for Chronic Obstructive Pulmonary Disorder (COPD) in Japan. The inhalable product... 2006-11-20

In a possible change to its core growth strategy, leading Japanese drugmaker Takeda could be poised to make another large acquisition. The company - which has estimated cash reserves... 2006-11-15